Global High Dose Rate (HDR) Brachytherapy Market

High Dose Rate (HDR) Brachytherapy Comprehensive Study by Application (Prostate Cancer, Cervical Cancer, Breast cancer, Skin Cancer), Device (After loader, Applicators), Brachytherapy types (Mold brachytherapy, Interstitial brachytherapy, Intercavitary brachytherapy, Intravascular brachytherapy), Treatment machine (Manual Afterloading, Remote Afterloading) Players and Region - Global Market Outlook to 2030

High Dose Rate (HDR) Brachytherapy Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 73.4%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About High Dose Rate (HDR) Brachytherapy
High dose rate brachytherapy is also known as temporary brachytherapy. In Brachytherapy, which is a type of internal radiotherapy, the tubes are inserted into the prostate gland and a source of radiation is passed to destroy the cancer cells. When HDR brachytherapy taken together with external beam radio therapy, the individual with medium to high risk prostate cancer gets a higher dose. It has various advantages such as lesser time required for treatment, quick recovery, and low risk of side effects. According to the World Health Organization, 70% fatalities related to cancer occur in low and middle income countries.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR73.4%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global High Dose Rate (HDR) Brachytherapy market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Eckert & Ziegler BEBIG (Germany), IsoRay Medical, Inc. (United States), Elekta AB (Sweden), Varian Medical Systems, Inc. (United States), Lumitos AG (Germany), C.R Bard Inc. (United States), Argon Medical Devices (United States) and IsoAid (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global High Dose Rate (HDR) Brachytherapy market by , Application (Prostate Cancer, Cervical Cancer, Breast cancer and Skin Cancer) and Region.



On the basis of geography, the market of High Dose Rate (HDR) Brachytherapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the High Dose Rate (HDR) Brachytherapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increased adoption of radiotherapy by physicians

Market Growth Drivers:
Wide range of applications are of HDR brachytherapy is driving the market. These include, low risk, minimal side effects and lesser time required for treatment.

Challenges:
Side effects and Risks with HDR brachytherapy may hinder the market

Restraints:
Availability of other treatments for cancer

Opportunities:
Technological developments along with Research and developments initiatives and Rising number of cases associated with cancer

Market Leaders and their expansionary development strategies
In October 2021, Blue Wolf Capital Partners LLC, a New York-based private equity company, announced that it has reached a deal with Roper Technologies, Inc. to buy CIVCO Radiation, a provider of radiotherapy patient placement and immobilization technology.
In August 2020, Elekta announced that the Geneva brachytherapy applicator it created has obtained FDA approval in the United States, indicating that it would now permit cancer patients to use the applicator in the United States to access its precise treatment capabilities.


Key Target Audience
Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organisations

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Prostate Cancer
  • Cervical Cancer
  • Breast cancer
  • Skin Cancer
By Device
  • After loader
  • Applicators

By Brachytherapy types
  • Mold brachytherapy
  • Interstitial brachytherapy
  • Intercavitary brachytherapy
  • Intravascular brachytherapy

By Treatment machine
  • Manual Afterloading
  • Remote Afterloading

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Wide range of applications are of HDR brachytherapy is driving the market. These include, low risk, minimal side effects and lesser time required for treatment.
    • 3.3. Market Challenges
      • 3.3.1. Side effects and Risks with HDR brachytherapy may hinder the market
    • 3.4. Market Trends
      • 3.4.1. Increased adoption of radiotherapy by physicians
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global High Dose Rate (HDR) Brachytherapy, by Application, Device , Brachytherapy types, Treatment machine and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global High Dose Rate (HDR) Brachytherapy (Value)
      • 5.2.1. Global High Dose Rate (HDR) Brachytherapy by: Application (Value)
        • 5.2.1.1. Prostate Cancer
        • 5.2.1.2. Cervical Cancer
        • 5.2.1.3. Breast cancer
        • 5.2.1.4. Skin Cancer
      • 5.2.2. Global High Dose Rate (HDR) Brachytherapy by: Brachytherapy types (Value)
        • 5.2.2.1. Mold brachytherapy
        • 5.2.2.2. Interstitial brachytherapy
        • 5.2.2.3. Intercavitary brachytherapy
        • 5.2.2.4. Intravascular brachytherapy
      • 5.2.3. Global High Dose Rate (HDR) Brachytherapy by: Treatment machine (Value)
        • 5.2.3.1. Manual Afterloading
        • 5.2.3.2. Remote Afterloading
      • 5.2.4. Global High Dose Rate (HDR) Brachytherapy Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global High Dose Rate (HDR) Brachytherapy (Price)
  • 6. High Dose Rate (HDR) Brachytherapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Eckert & Ziegler BEBIG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. IsoRay Medical, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Elekta AB (Sweden)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Varian Medical Systems, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Lumitos AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. C.R Bard Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Argon Medical Devices (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. IsoAid (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global High Dose Rate (HDR) Brachytherapy Sale, by Application, Device , Brachytherapy types, Treatment machine and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global High Dose Rate (HDR) Brachytherapy (Value)
      • 7.2.1. Global High Dose Rate (HDR) Brachytherapy by: Application (Value)
        • 7.2.1.1. Prostate Cancer
        • 7.2.1.2. Cervical Cancer
        • 7.2.1.3. Breast cancer
        • 7.2.1.4. Skin Cancer
      • 7.2.2. Global High Dose Rate (HDR) Brachytherapy by: Brachytherapy types (Value)
        • 7.2.2.1. Mold brachytherapy
        • 7.2.2.2. Interstitial brachytherapy
        • 7.2.2.3. Intercavitary brachytherapy
        • 7.2.2.4. Intravascular brachytherapy
      • 7.2.3. Global High Dose Rate (HDR) Brachytherapy by: Treatment machine (Value)
        • 7.2.3.1. Manual Afterloading
        • 7.2.3.2. Remote Afterloading
      • 7.2.4. Global High Dose Rate (HDR) Brachytherapy Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global High Dose Rate (HDR) Brachytherapy (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. High Dose Rate (HDR) Brachytherapy: by Application(USD Million)
  • Table 2. High Dose Rate (HDR) Brachytherapy Prostate Cancer , by Region USD Million (2018-2023)
  • Table 3. High Dose Rate (HDR) Brachytherapy Cervical Cancer , by Region USD Million (2018-2023)
  • Table 4. High Dose Rate (HDR) Brachytherapy Breast cancer , by Region USD Million (2018-2023)
  • Table 5. High Dose Rate (HDR) Brachytherapy Skin Cancer , by Region USD Million (2018-2023)
  • Table 6. High Dose Rate (HDR) Brachytherapy: by Brachytherapy types(USD Million)
  • Table 7. High Dose Rate (HDR) Brachytherapy Mold brachytherapy , by Region USD Million (2018-2023)
  • Table 8. High Dose Rate (HDR) Brachytherapy Interstitial brachytherapy , by Region USD Million (2018-2023)
  • Table 9. High Dose Rate (HDR) Brachytherapy Intercavitary brachytherapy , by Region USD Million (2018-2023)
  • Table 10. High Dose Rate (HDR) Brachytherapy Intravascular brachytherapy , by Region USD Million (2018-2023)
  • Table 11. High Dose Rate (HDR) Brachytherapy: by Treatment machine(USD Million)
  • Table 12. High Dose Rate (HDR) Brachytherapy Manual Afterloading , by Region USD Million (2018-2023)
  • Table 13. High Dose Rate (HDR) Brachytherapy Remote Afterloading , by Region USD Million (2018-2023)
  • Table 14. South America High Dose Rate (HDR) Brachytherapy, by Country USD Million (2018-2023)
  • Table 15. South America High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 16. South America High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 17. South America High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 18. South America High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 19. Brazil High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 20. Brazil High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 21. Brazil High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 22. Brazil High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 23. Argentina High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 24. Argentina High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 25. Argentina High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 26. Argentina High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 27. Rest of South America High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 28. Rest of South America High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 29. Rest of South America High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 30. Rest of South America High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 31. Asia Pacific High Dose Rate (HDR) Brachytherapy, by Country USD Million (2018-2023)
  • Table 32. Asia Pacific High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 33. Asia Pacific High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 34. Asia Pacific High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 35. Asia Pacific High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 36. China High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 37. China High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 38. China High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 39. China High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 40. Japan High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 41. Japan High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 42. Japan High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 43. Japan High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 44. India High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 45. India High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 46. India High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 47. India High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 48. South Korea High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 49. South Korea High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 50. South Korea High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 51. South Korea High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 52. Taiwan High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 53. Taiwan High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 54. Taiwan High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 55. Taiwan High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 56. Australia High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 57. Australia High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 58. Australia High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 59. Australia High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 60. Rest of Asia-Pacific High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 61. Rest of Asia-Pacific High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 64. Europe High Dose Rate (HDR) Brachytherapy, by Country USD Million (2018-2023)
  • Table 65. Europe High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 66. Europe High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 67. Europe High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 68. Europe High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 69. Germany High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 70. Germany High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 71. Germany High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 72. Germany High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 73. France High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 74. France High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 75. France High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 76. France High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 77. Italy High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 78. Italy High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 79. Italy High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 80. Italy High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 81. United Kingdom High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 82. United Kingdom High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 83. United Kingdom High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 84. United Kingdom High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 85. Netherlands High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 86. Netherlands High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 87. Netherlands High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 88. Netherlands High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 89. Rest of Europe High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 90. Rest of Europe High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 91. Rest of Europe High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 92. Rest of Europe High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 93. MEA High Dose Rate (HDR) Brachytherapy, by Country USD Million (2018-2023)
  • Table 94. MEA High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 95. MEA High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 96. MEA High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 97. MEA High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 98. Middle East High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 99. Middle East High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 100. Middle East High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 101. Middle East High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 102. Africa High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 103. Africa High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 104. Africa High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 105. Africa High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 106. North America High Dose Rate (HDR) Brachytherapy, by Country USD Million (2018-2023)
  • Table 107. North America High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 108. North America High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 109. North America High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 110. North America High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 111. United States High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 112. United States High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 113. United States High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 114. United States High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 115. Canada High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 116. Canada High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 117. Canada High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 118. Canada High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 119. Mexico High Dose Rate (HDR) Brachytherapy, by Application USD Million (2018-2023)
  • Table 120. Mexico High Dose Rate (HDR) Brachytherapy, by Device USD Million (2018-2023)
  • Table 121. Mexico High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2018-2023)
  • Table 122. Mexico High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2018-2023)
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. High Dose Rate (HDR) Brachytherapy: by Application(USD Million)
  • Table 132. High Dose Rate (HDR) Brachytherapy Prostate Cancer , by Region USD Million (2025-2030)
  • Table 133. High Dose Rate (HDR) Brachytherapy Cervical Cancer , by Region USD Million (2025-2030)
  • Table 134. High Dose Rate (HDR) Brachytherapy Breast cancer , by Region USD Million (2025-2030)
  • Table 135. High Dose Rate (HDR) Brachytherapy Skin Cancer , by Region USD Million (2025-2030)
  • Table 136. High Dose Rate (HDR) Brachytherapy: by Brachytherapy types(USD Million)
  • Table 137. High Dose Rate (HDR) Brachytherapy Mold brachytherapy , by Region USD Million (2025-2030)
  • Table 138. High Dose Rate (HDR) Brachytherapy Interstitial brachytherapy , by Region USD Million (2025-2030)
  • Table 139. High Dose Rate (HDR) Brachytherapy Intercavitary brachytherapy , by Region USD Million (2025-2030)
  • Table 140. High Dose Rate (HDR) Brachytherapy Intravascular brachytherapy , by Region USD Million (2025-2030)
  • Table 141. High Dose Rate (HDR) Brachytherapy: by Treatment machine(USD Million)
  • Table 142. High Dose Rate (HDR) Brachytherapy Manual Afterloading , by Region USD Million (2025-2030)
  • Table 143. High Dose Rate (HDR) Brachytherapy Remote Afterloading , by Region USD Million (2025-2030)
  • Table 144. South America High Dose Rate (HDR) Brachytherapy, by Country USD Million (2025-2030)
  • Table 145. South America High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 146. South America High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 147. South America High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 148. South America High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 149. Brazil High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 150. Brazil High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 151. Brazil High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 152. Brazil High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 153. Argentina High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 154. Argentina High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 155. Argentina High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 156. Argentina High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 157. Rest of South America High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 158. Rest of South America High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 159. Rest of South America High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 160. Rest of South America High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 161. Asia Pacific High Dose Rate (HDR) Brachytherapy, by Country USD Million (2025-2030)
  • Table 162. Asia Pacific High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 163. Asia Pacific High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 164. Asia Pacific High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 165. Asia Pacific High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 166. China High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 167. China High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 168. China High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 169. China High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 170. Japan High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 171. Japan High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 172. Japan High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 173. Japan High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 174. India High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 175. India High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 176. India High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 177. India High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 178. South Korea High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 179. South Korea High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 180. South Korea High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 181. South Korea High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 182. Taiwan High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 183. Taiwan High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 184. Taiwan High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 185. Taiwan High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 186. Australia High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 187. Australia High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 188. Australia High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 189. Australia High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 190. Rest of Asia-Pacific High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 191. Rest of Asia-Pacific High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 192. Rest of Asia-Pacific High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 193. Rest of Asia-Pacific High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 194. Europe High Dose Rate (HDR) Brachytherapy, by Country USD Million (2025-2030)
  • Table 195. Europe High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 196. Europe High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 197. Europe High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 198. Europe High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 199. Germany High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 200. Germany High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 201. Germany High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 202. Germany High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 203. France High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 204. France High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 205. France High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 206. France High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 207. Italy High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 208. Italy High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 209. Italy High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 210. Italy High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 211. United Kingdom High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 212. United Kingdom High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 213. United Kingdom High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 214. United Kingdom High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 215. Netherlands High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 216. Netherlands High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 217. Netherlands High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 218. Netherlands High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 219. Rest of Europe High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 220. Rest of Europe High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 221. Rest of Europe High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 222. Rest of Europe High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 223. MEA High Dose Rate (HDR) Brachytherapy, by Country USD Million (2025-2030)
  • Table 224. MEA High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 225. MEA High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 226. MEA High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 227. MEA High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 228. Middle East High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 229. Middle East High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 230. Middle East High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 231. Middle East High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 232. Africa High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 233. Africa High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 234. Africa High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 235. Africa High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 236. North America High Dose Rate (HDR) Brachytherapy, by Country USD Million (2025-2030)
  • Table 237. North America High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 238. North America High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 239. North America High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 240. North America High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 241. United States High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 242. United States High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 243. United States High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 244. United States High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 245. Canada High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 246. Canada High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 247. Canada High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 248. Canada High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 249. Mexico High Dose Rate (HDR) Brachytherapy, by Application USD Million (2025-2030)
  • Table 250. Mexico High Dose Rate (HDR) Brachytherapy, by Device USD Million (2025-2030)
  • Table 251. Mexico High Dose Rate (HDR) Brachytherapy, by Brachytherapy types USD Million (2025-2030)
  • Table 252. Mexico High Dose Rate (HDR) Brachytherapy, by Treatment machine USD Million (2025-2030)
  • Table 253. Research Programs/Design for This Report
  • Table 254. Key Data Information from Secondary Sources
  • Table 255. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global High Dose Rate (HDR) Brachytherapy: by Application USD Million (2018-2023)
  • Figure 5. Global High Dose Rate (HDR) Brachytherapy: by Brachytherapy types USD Million (2018-2023)
  • Figure 6. Global High Dose Rate (HDR) Brachytherapy: by Treatment machine USD Million (2018-2023)
  • Figure 7. South America High Dose Rate (HDR) Brachytherapy Share (%), by Country
  • Figure 8. Asia Pacific High Dose Rate (HDR) Brachytherapy Share (%), by Country
  • Figure 9. Europe High Dose Rate (HDR) Brachytherapy Share (%), by Country
  • Figure 10. MEA High Dose Rate (HDR) Brachytherapy Share (%), by Country
  • Figure 11. North America High Dose Rate (HDR) Brachytherapy Share (%), by Country
  • Figure 12. Global High Dose Rate (HDR) Brachytherapy share by Players 2023 (%)
  • Figure 13. Global High Dose Rate (HDR) Brachytherapy share by Players (Top 3) 2023(%)
  • Figure 14. Global High Dose Rate (HDR) Brachytherapy share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Eckert & Ziegler BEBIG (Germany) Revenue, Net Income and Gross profit
  • Figure 17. Eckert & Ziegler BEBIG (Germany) Revenue: by Geography 2023
  • Figure 18. IsoRay Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. IsoRay Medical, Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Elekta AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 21. Elekta AB (Sweden) Revenue: by Geography 2023
  • Figure 22. Varian Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Varian Medical Systems, Inc. (United States) Revenue: by Geography 2023
  • Figure 24. Lumitos AG (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Lumitos AG (Germany) Revenue: by Geography 2023
  • Figure 26. C.R Bard Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. C.R Bard Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Argon Medical Devices (United States) Revenue, Net Income and Gross profit
  • Figure 29. Argon Medical Devices (United States) Revenue: by Geography 2023
  • Figure 30. IsoAid (United States) Revenue, Net Income and Gross profit
  • Figure 31. IsoAid (United States) Revenue: by Geography 2023
  • Figure 32. Global High Dose Rate (HDR) Brachytherapy: by Application USD Million (2025-2030)
  • Figure 33. Global High Dose Rate (HDR) Brachytherapy: by Brachytherapy types USD Million (2025-2030)
  • Figure 34. Global High Dose Rate (HDR) Brachytherapy: by Treatment machine USD Million (2025-2030)
  • Figure 35. South America High Dose Rate (HDR) Brachytherapy Share (%), by Country
  • Figure 36. Asia Pacific High Dose Rate (HDR) Brachytherapy Share (%), by Country
  • Figure 37. Europe High Dose Rate (HDR) Brachytherapy Share (%), by Country
  • Figure 38. MEA High Dose Rate (HDR) Brachytherapy Share (%), by Country
  • Figure 39. North America High Dose Rate (HDR) Brachytherapy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Eckert & Ziegler BEBIG (Germany)
  • IsoRay Medical, Inc. (United States)
  • Elekta AB (Sweden)
  • Varian Medical Systems, Inc. (United States)
  • Lumitos AG (Germany)
  • C.R Bard Inc. (United States)
  • Argon Medical Devices (United States)
  • IsoAid (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 236 Pages 68 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global High Dose Rate (HDR) Brachytherapy Market Quantitative research analysis
Global High Dose Rate (HDR) Brachytherapy Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Eckert & Ziegler BEBIG (Germany), IsoRay Medical, Inc. (United States), Elekta AB (Sweden), Varian Medical Systems, Inc. (United States), Lumitos AG (Germany), C.R Bard Inc. (United States), Argon Medical Devices (United States) and IsoAid (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increased adoption of radiotherapy by physicians" is seen as one of major influencing trends for High Dose Rate (HDR) Brachytherapy Market during projected period 2023-2030.
The High Dose Rate (HDR) Brachytherapy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global High Dose Rate (HDR) Brachytherapy Market Report?

Have a Query? Click Here

Other Related Reports

Ambulatory Practice Management Software Comprehensive Study by Deployment Mode (Cloud, On-Premise), Platform (MacOS, Windows, Linux), End - Users (Hospitals, Clinics, Laboratories, Others), Operation...
$ 3800
Hair Loss Medication Comprehensive Study by Type (Minoxidil Solution, Herbal Extract Treatment, Other), Application (Male, Female), Distribution Channel (Offline, Online), End Use (Dermatology clinic...
$ 3500
Critical Care Analyzer Comprehensive Study by Type (Wireless, Cable), Application (Central Nervous System Failure, Circulatory Failure, Shock, Metabolic, Respiratory Failure), End Use (Intensive care...
$ 3450
Travel Medical Service Comprehensive Study by Type (Heavy Medical Mode, Light Medical Model, Comprehensive Health Care, Others), Application (Cosmetic Medicine, Disease Treatment, Other), Travel type...
$ 3650
Patient Blood Management Comprehensive Study by Type (Transfusion Device, Accessories, Software, Reagents and Kits, Others), Application (Hospitals, Blood Banks, Pathology Labs, Others), Components (...
$ 3750
Sexually Transmitted Disease Treatment Comprehensive Study by Type (Chlamydia, Gonorrhea, Syphilis, Hepatitis B, Genital herpes, HIV/AIDS, Human Papillomavirus, Crabs/Pubic Lice, Others), Application...
$ 3750